Ubs Group Ag Integra Lifesciences Holdings Corp Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Ubs Group Ag holds 79,404 shares of IART stock, worth $1.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

79,404

Previous 32,317 145.7%

Holding current value

$1.76 Million

Previous $941,000 53.24%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$17.14 - $31.74 $807,071 - $1.49 Million	47,087 Added 145.7%	79,404 $1.44 Million
Q2 2024 Aug 13, 2024	SELL	$23.14 - $34.72 $188,868 - $283,384	-8,162 Reduced 20.16%	32,317 $941,000
Q1 2024 May 13, 2024	BUY	$33.4 - $45.2 $489,243 - $662,089	14,648 Added 56.71%	40,479 $1.43 Million
Q4 2023 Feb 09, 2024	SELL	$34.21 - $44.59 $261,159 - $340,400	-7,634 Reduced 22.81%	25,831 $1.12 Million
Q3 2023 Nov 09, 2023	BUY	$37.8 - $45.97 $1.12 Million - $1.36 Million	29,538 Added 752.18%	33,465 $1.28 Million
Q2 2023 Aug 11, 2023	SELL	$37.95 - $58.98 $13,168 - $20,466	-347 Reduced 8.12%	3,927 $161,000
Q1 2023 May 12, 2023	SELL	$52.61 - $60.49 $222,855 - $256,235	-4,236 Reduced 49.78%	4,274 $245,000
Q4 2022 Feb 08, 2023	SELL	$42.17 - $58.6 $593,374 - $824,560	-14,071 Reduced 62.31%	8,510 $477,000
Q3 2022 Nov 10, 2022	BUY	$42.28 - $57.17 $385,128 - $520,761	9,109 Added 67.61%	22,581 $956,000
Q2 2022 Aug 10, 2022	SELL	$53.86 - $66.52 $69,263 - $85,544	-1,286 Reduced 8.71%	13,472 $728,000
Q1 2022 May 16, 2022	SELL	$62.86 - $69.24 $1.68 Million - $1.85 Million	-26,723 Reduced 64.42%	14,758 $948,000
Q4 2021 Feb 14, 2022	BUY	$62.47 - $73.25 $499,322 - $585,487	7,993 Added 23.87%	41,481 $2.78 Million
Q3 2021 Nov 15, 2021	SELL	$64.97 - $76.19 $494,551 - $579,958	-7,612 Reduced 18.52%	33,488 $2.29 Million
Q2 2021 Aug 13, 2021	BUY	$66.79 - $76.63 $1.12 Million - $1.29 Million	16,800 Added 69.14%	41,100 $2.81 Million
Q1 2021 May 12, 2021	SELL	$62.63 - $71.15 $590,162 - $670,446	-9,423 Reduced 27.94%	24,300 $1.68 Million
Q4 2020 Feb 11, 2021	SELL	$43.31 - $66.55 $377,403 - $579,916	-8,714 Reduced 20.53%	33,723 $2.19 Million
Q3 2020 Nov 12, 2020	BUY	$43.33 - $51.72 $1.63 Million - $1.95 Million	37,631 Added 783.0%	42,437 $2 Million
Q2 2020 Jul 31, 2020	SELL	$41.42 - $55.57 $44,816 - $60,126	-1,082 Reduced 18.38%	4,806 $226,000
Q1 2020 May 01, 2020	SELL	$36.67 - $61.04 $1.92 Million - $3.2 Million	-52,445 Reduced 89.91%	5,888 $263,000
Q4 2019 Feb 14, 2020	BUY	$55.73 - $62.49 $2.23 Million - $2.51 Million	40,089 Added 219.74%	58,333 $3.4 Million
Q3 2019 Nov 14, 2019	BUY	$53.29 - $64.59 $679,500 - $823,587	12,751 Added 232.13%	18,244 $1.1 Million
Q2 2019 Aug 14, 2019	SELL	$46.45 - $55.85 $1.22 Million - $1.47 Million	-26,254 Reduced 82.7%	5,493 $307,000
Q1 2019 May 14, 2019	SELL	$42.97 - $57.33 $30,852 - $41,162	-718 Reduced 2.21%	31,747 $1.77 Million
Q4 2018 Feb 14, 2019	SELL	$42.62 - $64.51 $278,820 - $422,024	-6,542 Reduced 16.77%	32,465 $1.46 Million
Q3 2018 Nov 14, 2018	BUY	$57.63 - $65.87 $1.25 Million - $1.43 Million	21,669 Added 124.98%	39,007 $2.57 Million
Q2 2018 Aug 14, 2018	BUY	$54.05 - $67.23 $202,957 - $252,448	3,755 Added 27.64%	17,338 $1.12 Million
Q1 2018 May 15, 2018	SELL	$46.55 - $57.38 $1.49 Million - $1.83 Million	-31,903 Reduced 70.14%	13,583 $751,000
Q4 2017 Feb 14, 2018	SELL	$46.22 - $51.77 $1.05 Million - $1.17 Million	-22,610 Reduced 33.2%	45,486 $2.18 Million
Q3 2017 Nov 14, 2017	BUY	$47.8 - $53.63 $454,243 - $509,645	9,503 Added 16.22%	68,096 $3.44 Million
Q2 2017 Aug 14, 2017	BUY	N/A	5,200 Added 9.74%	58,593 $3.19 Million
Q1 2017 Nov 14, 2017	BUY	N/A	53,393	53,393 $2.25 Million

Others Institutions Holding IART

# of Institutions

241

Shares Held

75.3M

Call Options Held

585K

Put Options Held

21.3K

View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.85B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

More about IART

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account